发明授权
- 专利标题： Indazolyl-substituted pyrroline compounds as kinase inhibitors
- 专利标题（中）： 吲唑基取代的吡咯啉化合物作为激酶抑制剂
-
申请号： US10885373申请日： 2004-07-06
-
公开(公告)号： US07304060B2公开(公告)日： 2007-12-04
- 发明人: Han-Cheng Zhang , Bruce Maryanoff , Bruce Conway , Kimberly White , Hong Ye , Leonard Robert Hecker , David F. McComsey
- 申请人： Han-Cheng Zhang , Bruce Maryanoff , Bruce Conway , Kimberly White , Hong Ye , Leonard Robert Hecker , David F. McComsey
- 申请人地址： US NJ Raritan
- 专利权人： Ortho-McNeil Pharmaceutical, Inc.
- 当前专利权人： Ortho-McNeil Pharmaceutical, Inc.
- 当前专利权人地址： US NJ Raritan
- 主分类号： A61K31/5377
- IPC分类号： A61K31/5377 ; A61K31/497 ; A61K31/4709 ; A61K31/4439 ; C07D403/14 ; C07D217/22 ; C07D231/56
摘要：
The present invention is directed to novel indazolyl-substituted pyrroline compounds of Formula (I): useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.